South Korea · 
Who invested in Kanaph Therapeutics?
Kanaph Therapeutics's investors include Premier Partners, InterVest Co. and Aju IB Investment.
South Korea · Series C startup
Who invested in Kanaph Therapeutics
Funding summaryUpdated 26 Oct 2026
$18Mraised across 1 round since 2023, from 1 source
- Latest round
- Series C, $18MDec 2023
- Investors
- 3
The rounds
- Dec 2023
Founders and team
From Kanaph Therapeutics's own website.
AdvisersJason J. Luke M.D.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Kanaph Therapeutics
How much has Kanaph Therapeutics raised?
Kanaph Therapeutics has raised $18M across 1 round since 2023.
When did Kanaph Therapeutics last raise?
Kanaph Therapeutics's most recent round was a Series C of $18M in Dec 2023.
What was Kanaph Therapeutics's biggest round?
Its most recent round, $18M in Dec 2023, is also its largest on record.
Who backed Kanaph Therapeutics first?
Kanaph Therapeutics's first round on record, in Dec 2023, was backed by Premier Partners, InterVest Co. and Aju IB Investment.
What stage is Kanaph Therapeutics at?
Kanaph Therapeutics's latest named round is a Series C, in Dec 2023.
Where is Kanaph Therapeutics based?
Kanaph Therapeutics is based in South Korea.
Companies like Kanaph Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.